REFERENCES
- Lopez A D, Murray C C. The global burden of disease, 1990–2020. Nat Med 1998; 4: 1241–1243, [PUBMED], [INFOTRIEVE], [CSA]
- Barnes P J, Shapiro S D, Pauwels R A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22(4)672–688, [PUBMED], [INFOTRIEVE], [CSA]
- The National Awareness Panel. Guidelines for the early detection and management of COPD. J Respir Dis 2000; 21(Suppl. 9)5–21, [CSA]
- Pietila M P, Thomas C F. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease. Semin Respir Infect 2003; 18: 9–16, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Emre U, Roblin P M, Gelling M, Dumornay W, Rao M, Hammerschlag M R, Schacter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148(7)727–732, [PUBMED], [INFOTRIEVE], [CSA]
- Hahn D L, Bukstein D, Luskin A, Zeitz H. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 1998; 80(1)45–49, [PUBMED], [INFOTRIEVE], [CSA]
- Hahn D L, Dodge R W, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266(2)225–230, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gil J C, Cedillo R L, Mayagoitia B G, Paz M D. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993; 70(1)23–25, [PUBMED], [INFOTRIEVE], [CSA]
- Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 1994; 149(5)1348–1353, [PUBMED], [INFOTRIEVE], [CSA]
- Kraft M, Cassell G H, Henson J E, Watson H, Williamson J, Marmion B P, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998; 158(3)998–1001, [PUBMED], [INFOTRIEVE], [CSA]
- Martin R J, Kraft M, Chu H W, Berns E A, Cassell G H. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107(4)595–601, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kraft M, Cassell G H, Pak J, Martin R J. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002; 121(6)1782–1788, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chu H W, Kraft M, Krause J E, Rex M D, Martin R J. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000; 106(4)713–722, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Von Hertzen L, Alakarppa H, Koskinen R, Liippo K, Surcel H M, Leinonen M, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997; 118(2)155–164, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martin R J, Chu H W, Honour J M, Harbeck R J. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24(5)577–582, [PUBMED], [INFOTRIEVE], [CSA]
- Chu H W, Honour J M, Rawlinson C A, Harbeck R J, Martin R J. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003; 71(3)1520–1526, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Teague S V, Pinkerton K E, Goldsmith M, Gebremichael A, Chang S, Jenkins R A, et al. A sidestream cigarette smoking generator and exposure system for environmental tobacco smoke studies. J Inhal Toxicol 1994; 6: 79–93, [CSA]
- Smith K R, Uyeminami D L, Kodavanti U P, Crapo J D, Chang L Y, Pinkerton K E. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 2002; 33(8)1106–1114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Takubo Y, Guerassimov A, Ghezzo H, Triantafillopoulos A, Bates J H, Hoidal J R, et al. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. Am J Respir Crit Care Med 2002; 166(12 Pt 1)1596–1603, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Elliot J G, Carroll N G, James A L, Robinson P J. Airway alveolar attachment points and exposure to cigarette smoke in utero. Am J Respir Crit Care Med 2003; 167(1)45–49, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Howard C V, Reed M G. Unbiased sterology: three-dimensional measurement in microscopy. Springer Verlag, New York 1998
- Wenzel S E, Trudeau J B, Barnes S, Zhou X, Cundall M, Westcott J Y, et al. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 2002; 169(8)4613–4619, [PUBMED], [INFOTRIEVE], [CSA]
- Choe K H, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder R M, Voelkel N F. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167(11)1516–1521, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Culpitt S V, Maziak W, Loukidis S, Nightingale J A, Matthews J L, Barnes P J. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(5 Pt 1)1635–1639, [PUBMED], [INFOTRIEVE], [CSA]
- Shapiro S D, Senior R M. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999; 20(6)1100–1102, [PUBMED], [INFOTRIEVE], [CSA]
- Finlay G A, O'Driscoll L R, Russell K J, D'Arcy E M, Masterson J B, Fitz Gerald M X, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156(1)240–247, [PUBMED], [INFOTRIEVE], [CSA]
- Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999; 159(6)1985–1991, [PUBMED], [INFOTRIEVE], [CSA]
- Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen Y T. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78(9)1077–1087, [PUBMED], [INFOTRIEVE], [CSA]
- Russell R E, Culpitt S V, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26(5)602–609, [PUBMED], [INFOTRIEVE], [CSA]
- Elliott W M, Hayashi S, Hogg J C. Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995; 12(6)642–648, [PUBMED], [INFOTRIEVE], [CSA]
- Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies W A, Hogg J C. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146(1)177–184, [PUBMED], [INFOTRIEVE], [CSA]
- Cherry J D, Taylor-Robinson D, Willers H, Stenhouse A C. A search for mycoplasma infections in patients with chronic bronchitis. Thorax 1971; 26(1)62–67, [PUBMED], [INFOTRIEVE], [CSA]
- Clementsen P, Farholt S, Permin H, Lange P, Stahl Skov P, Norn S. Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls. Inflamm Res 2000; 49(Suppl 1)S37–38, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Theegarten D, Mogileuski G, Anhenn O, Stamatis G, Jaeschock R, Morgenroth K. The role of chlamydia in the pathogenesis of pulmonary emphysema. Virchows Arch 2000; 437: 190–193, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lambert H P. Antibody to Mycoplasma pneumoniae in normal subjects and in patients with chronic bronchitis. J Hyg Camb 1968; 66: 185–189, [PUBMED], [INFOTRIEVE], [CSA]